Effect of compromised skin barrier on delivery of diclofenac sodium from brand and generic formulations via microneedles and iontophoresis

Application of drugs on skin with compromised barrier can significantly alter permeation of drugs with the possibility of increased adverse side effects or even toxicity. In this study, we tested in vitro delivery of diclofenac sodium from marketed brand and generic formulations across normal and compromised skin using microneedles and iontophoresis, alone and in combination. Ten tape strips on dermatomed human skin were used to create a compromised skin model, as demonstrated by changes in skin resistance and transepidermal water loss. His-tology studies further confirmed creation of a compromised skin barrier. There was no significant difference between brand and generic formulations for delivery of diclofenac sodium into and across normal and compromised skin. Compromised skin showed higher total delivery (mu g/sq.cm) of diclofenac sodium for all groups - microneedles (brand: 79.45 +/- 8.81, generic: 92.15 +/- 8.63), iontophoresis (brand: 233.13 +/- 8.32, generic: 242.07 +/- 11.17), combination (brand: 186.88 +/- 6.76, generic: 193.8 +/- 5.69) as compared to intact normal skin for same groups, microneedles (brand: 21.83 +/- 1.96, generic: 20.38 +/- 0.91), iontophoresis (brand: 149.78 +/- 18.43, generic: 145.53 +/- 12.61), and combination (brand: 80.97 +/- 9.86, generic: 70.76 +/- 6.56). These results indicate the effect of barrier integrity on delivery of diclofenac sodium which suggests increased absorption and systemic exposure of the drug across skin with compromised skin barrier.